Resveratrol in Endometriosis: a review of clinical studies
Abstract
Introduction: Endometriosis is a gynecological condition of late and ineffective diagnosis and treatment, respectively, making it a serious public health problem. Resveratrol is a natural phenolic compound that has antioxidant, anti-inflammatory, cardioprotective, antidiabetic, anticancer, chemopreventive and neuroprotective properties, with very promising results when used in some human conditions. Objective: In this sense, this study aims to describe the role of resveratrol in endometriosis. Materials and Methods: An electronic search was carried out in the main databases in the health area: PubMed, LILACS, Web of Science, Cochrane, EMBASE, CINAHL, without time limits, using the official descriptors endometriosis and resveratrol. Only studies in human beings, of the clinical trial type, published in the English language, were included. Results: The electronic search resulted in 128 articles, 74 of which were repeated and therefore removed. After applying the eligibility criteria, the total number of articles included in this systematic review was four. Two studies demonstrated that resveratrol promoted a reduction in the expression levels of Matrix Metalloproteinases (MMP-2 and MMP-9), Vascular Endothelial Growth Factor (VEGF) and Tumor Necrosis Factor α (TNF-α) and the other two studies evaluated the effect of resveratrol in the management of pain related to endometriosis, with antagonistic results. Conclusion: The studies included in this review show the role of resveratrol in controlling pain, inflammation and angiogenesis in endometriosis. Well-designed clinical studies must be conducted to corroborate these very promising results so far.
References
-Afrin, S.; AlAshqar, A.; El Sabeh, M.; Miyashita-Ishiwata, M.; Reschke, L.; Brennan, J.T.; Fader, A.; Borahay, M.A. Diet and Nutrition in Gynecological Disorders: A Focus on Clinical Studies. Nutrients. Vol. 13. Num. 6. 2021. p. 1747.
-Amaral, L.A.; Tonini, I.G.O.; Medino, I.C.; Ribas, B.A.; Silva, T.K.R.; Tortorella, C.C.C.S. Efeitos da suplementação de resveratrol na saúde humana: uma revisão integrativa. Visão Acadêmica. Vol. 19. Num. 3. 2018.
-Arablou, T.; Aryaeian, N.; Khodaverdi, S.; Kolahdouz-Mohammadi, R.; Moradi, Z.; Rashidi, N.; Delbandi, A.A. The effects of resveratrol on the expression of VEGF, TGF-β, and MMP-9 in endometrial stromal cells of women with endometriosis. Scientific Reports. Vol. 11. Num. 1. 2021. p. 6054.
-Arafah, M.; Rashid, S.; Akhtar, M. Endometriosis: A Comprehensive Review. Advances in Anatomic Pathology. Vol. 28. Num. 1. 2021. p. 30-43.
-Bahramrezaie, M.; Amidi, F.; Aleyasin, A.; Saremi, A.; Aghahoseini, M.; Brenjian, S.; Khodarahmian, M.; Pooladi, A. Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial. Journal of Assisted Reproduction and Genetics. Vol. 36. Num. 8. 2019. p.1701-1712.
-Barbe, A.M.; Berbets, A.M.; Davydenko, I.S.; Koval, H.D.; Yuzko, V.O.; Yuzko, O.M. Expression and Significance of Matrix Metalloproteinase-2 and Matrix Metalloproteinas-9 in Endometriosis. Journal of Medicine and Life. Vol. 13. Num. 3. 2020. p. 314-320.
-Brenjian, S.; Moini, A.; Yamini, N.; Kashani, L.; Faridmojtahedi, M.; Bahramrezaie, M.; Khodarahmian, M.; Amidi, F. Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers. American Journal of Reproductive Immunology. Vol. 83. Num. 1. 2020. p. e13186.
-Cai, X.; Liu, M.; Zhang, B.; Zhao, S.J.; Jiang, S.W. Phytoestrogens for the Management of Endometriosis: Findings and Issues. Pharmaceuticals. Vol. 14. Num. 6. 2021. p. 569.
-Cardoso, J.V.; Machado, D.E.; Silva, M.C. da, Berardo, P.T.; Abrão, M.S.; Ferrari, R.; Perini, J.A. Epidemiological profile of women with endometriosis: a retrospective descriptive study. Revista Brasileira de Saúde Materno Infantil. Vol. 20. Num. 4. 2020.
-Chung, M.S.; Han, S.J. Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis. Frontiers in Global Womens Health. Vol. 3. 2022. p.856316.
-Cozzolino, M.; Coccia, M.E.; Lazzeri, G.; Basile, F.; Troiano, G. Variables Associated with Endometriosis-related Pain: A Pilot Study using a Visual Analogue Scale. Revista Brasileira de Ginecologia e Obstetrícia. Vol. 41. Num. 3. 2019. p. 170-175.
-Figueira, T.B.N.; Cechinel Zanchett, C.C. Resveratrol: papel nas doenças cardiovasculares. Revista Brasileira Multidisciplinar. Vol. 22. Num. 2. 2019.
-Halpern, G.; Schor, E.; Kopelman, A. Nutritional aspects related to endometriosis. Revista da Associação Médica Brasileira. Vol. 61. Num. 6. 2015. p. 519-523.
-Hipólito-Reis, M.; Neto, A.C.; Neves, D. Impact of curcumin, quercetin, or resveratrol on the pathophysiology of endometriosis: A systematic review. Phytotherapy Research. Vol. 36. Num. 6. 2022. p. 2416-2433.
-Jiang, T.; Chen, Y.; Gu, X.; Miao, M.; Hu, D.; Zhou, H.; Chen, J.; Teichmann, A.T.; Yang, Y. Review of the Potential Therapeutic Effects and Molecular Mechanisms of Resveratrol on Endometriosis. International Journal Womens Health. Vol. 15. 2023. p. 741-763.
-Ke, J.; Ye, J.; Li, M.; Zhu, Z. The Role of Matrix Metalloproteinases in Endometriosis: A Potential Target. Biomolecules. Vol. 11. Num. 11. 2021. p. 1739.
-Khodabandehloo, H.; Seyyedebrahimi, S.; Esfahani, E.N.; Razi, F.; Meshkani, R. Resveratrol supplementation decreases blood glucose without changing the circulating CD14+CD16+ monocytes and inflammatory cytokines in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. Nutrition Research. Vol. 54. 2018. p. 40-51.
-Kodarahmian, M.; Amidi, F.; Moini, A.; Kashani, L.; Shabani Nashtaei, M.; Pazhohan, A.; Bahramrezai, M.; Berenjian, S.; Sobhani, A. The modulating effects of Resveratrol on the expression of MMP-2 and MMP-9 in endometriosis women: a randomized exploratory trial. Gynecological Endocrinology. Vol. 35. Num. 8. 2019. p. 719-726.
-Khodarahmian, M.; Amidi, F.; Moini, A.; Kashani, L.; Salahi, E.; Danaii-Mehrabad, S.; Nashtaei, M.S.; Mojtahedi, M.F; Esfandyari, S.; Sobhani, A. A randomized exploratory trial to assess the effects of resveratrol on VEGF and TNF-α 2 expression in endometriosis women. Journal of Reproductive Immunology. Vol. 143. 2021. p. 103248.
-Kolahdouz Mohammadi, R.; Arablou, T. Resveratrol and endometriosis: In vitro and animal studies and underlying mechanisms (Review). Biomedicine Pharmacotherapy. Vol. 91. 2017. p. 220-228.
-Lai, Z.Z.; Yang, H.L.; Ha, S.Y.; Chang, K.K.; Mei, J.; Zhou, W.J.; Qiu, X.M.; Wang, X.Q.; Zhu, R.; Li, D.J.; Li, M.Q. Cyclooxygenase-2 in Endometriosis. International Journal of Biological Sciences. Vol. 15. Num. 13. 2019. p. 2783-2797.
-Leuenberger, J.; Kohl Schwartz, A.S.; Geraedts, K.; Haeberlin, F.; Eberhard, M.; von Orellie, S.; Imesch, P.; Leeners, B. Living with endometriosis: Comorbid pain disorders, characteristics of pain and relevance for daily life. European Journal Pain. Vol. 26. Num. 5. 2022. p. 1021-1038.
-Liu, C.; Li, Y.; Hu, S.; Chen, Y.; Gao, L.; Liu, D.; Guo, H.; Yang, Y. Clinical significance of matrix metalloproteinase-2 in endometrial cancer: A systematic review and meta-analysis. Medicine (Baltimore). Vol. 97. Num. 29. 2018. p. e10994.
-Madanes, D.; Meresman, G.; Valla, S.A.; Hassan, N.; Kiesel, L.; Greve, B.; Barañao, R.I.; Götte, M.; Ricci, A.G. Resveratrol impairs cellular mechanisms associated with the pathogenesis of endometriosis. Reproductive Biomedicine Online. Vol. 44. Num. 6. 2022. p. 976-990.
-Maia, H. Jr.; Haddad, C.; Pinheiro, N.; Casoy, J. Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain. International Journal Womens Health. Vol. 4. 2012. p. 543-549.
-Mendes da Silva, D.; Gross, L.A.; Neto, E.P.G.; Lessey, B.A.; Savaris, R.F. The Use of Resveratrol as an Adjuvant Treatment of Pain in Endometriosis: A Randomized Clinical Trial. Journal of the Endocrine Society. Vol. 1. Num. 4. 2017. p. 359-369.
-Mori, T.; Ito, F.; Koshiba, A.; Kataoka, H.; Tanaka, Y.; Okimura, H.; Khan, K.N.; Kitawaki, J. Aromatase as a target for treating endometriosis. Journal of Obstétrica and Gynaecology Research. Vol. 44. Num. 9. 2018. p. 1673-1681.
-Neumann, R.; Farias, N.L.; Rizzi, T.; Pretto, A.D.B. Influência da alimentação indivíduos com endometriose: uma revisão sistemática. Revista Brasileira de Obesidade, Nutrição e Emagrecimento. Vol. 17. Num. 106. 2023. p. 21-26.
-Rosa e Silva, J.C.; Valerio, F.P.; Herren, H.; Troncon, J.K.; Garcia, R.; Poli Neto, O.B. Endometriose - Aspectos clínicos do diagnóstico ao tratamento. Femina. Vol. 49. Num. 3. 2021. p. 134-141.
-Santos, G.A.A.; Pardi, P.C.; Aguiar, E.E.G. O uso de curcumina e do resveratrol no tratamento da Doença de Alzheimer: evidências científicas. Brazilian Journal of Health and Pharmacy. Vol. 1. Num. 2. 2019. p. 80-87.
-Seyyedebrahimi, S.; Khodabandehloo, H.; Nasli Esfahani, E.; Meshkani, R. The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. Acta Diabetologica. Vol. 55. Num. 4. 2018. p. 341-353.
-Smolarz, B.; Szyłło, K.; Romanowicz, H. Endometriosis: Epidemiology, Classification, Pathogenesis, Treatment and Genetics (Review of Literature). International Journal of Molecular Sciences. Vol. 22. Num. 19. 2021. p. 10554.
-Sui, X.; Li, Y.; Sun, Y.; Li, C.; Li, X,p.; Zhang, G. Expression and significance of autophagy genes LC3, Beclin1 and MMP-2 in endometriosis. Experimental Therapeutic Medicine. Vol. 16. Num. 3. 2018. p. 1958-1962.
-Sukan, B.; Akdevelioğlu, Y.; Sukan, V.N. Effect of Antioxidant Supplementation on Endometriosis-Related Pain: A Systematic Review. Current Nutrition Reports. Vol. 11. Num. 4. 2022. p. 753-764.
-Sverrisdóttir, U.Á.; Hansen, S.; Rudnicki, M. Impact of diet on pain perception in women with endometriosis: A systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology. Vol. 271. 2022. p. 245-249.
-Uchoa, S.N.S.; Figueira, L.L.; Dias, D.A.M. O potencial efeito do resveratrol no tratamento da endometriose. Research, Society and Development. Vol. 11. Num. 8. 2022.
-Vatavuk-Serrati, G.; Alves, R.T.; Costa, E.S.; Castro, A.G.P.; Machado, V.M. Efeitos da suplementação de resveratrol sobre fatores de risco cardiovascular. Revista da Sociedade de Cardiologia do Estado de São Paulo. Vol. 29. Num. 1. 2019. p. 88-93.
-Wang, X.M.; Ma, Z.Y.; Song, N. Inflammatory cytokines IL-6, IL-10, IL-13, TNF-α and peritoneal fluid flora were associated with infertility in patients with endometriosis. European Review Medical and Pharmacological Sciences. Vol. 22. Num. 9. 2018. p. 2513-2518.
-Warzecha, D.; Szymusik, I.; Wielgos, M.; Pietrzak, B. The Impact of Endometriosis on the Quality of Life and the Incidence of Depression-A Cohort Study. Internacional Journal of Environmental Research and Public Health. Vol. 17. Num. 10. 2020. p. 3641.
Copyright (c) 2024 Munique Alvarenga Nunes, Alessandra Bernadete Trovó de Marqui
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with work simultaneously licensed under the Creative Commons Attribution License BY-NC which allows the sharing of the work with acknowledgment of the authorship of the work and initial publication in this journal.
- Authors are authorized to enter into additional contracts separately for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to post and distribute their work online (eg, in institutional repositories or on their personal page) at any point before or during the editorial process, as this can bring about productive change as well as increase impact and impact. citation of published work (See The Effect of Free Access).
